Sunshine UK

Declaration on 7 March 2019

Benefits received from pharmaceutical companies

Company: Pharmaceutical companies · Reason for receipt of fees: Trainers Conference · Total amount received: under £100

Other sources of income or benefits from other organisations relevant to medical practice

Company: AXA PPP · Reason for receipt of fees: Medical Consultancy · Total amount received: £50,000 to under £100,000
Company: Public Health England · Reason for receipt of fees: Medical consultancy on antimicrobial stewardship · Total amount received: £1,000 to under £2,000
Company: Cogora · Reason for receipt of fees: Paper on antimicrobial stewardship to presented at Pulse Live conference · Total amount received: £100 to under £1,000

Fees directly received from other medical companies

Company: GP Care · Reason for receipt of fees: The practice is a small shareholder in GP care which is a Bristol based federation of >100 practices formed to improved services in primary care · Total amount received: under £100
Company: One Care · Reason for receipt of fees: The practice also has membership of the One care Consortium which received funding in 2014 and 2015 from the Prime Ministers Challenge Fund to increase access to primary care. · Total amount received: under £100
Company: NIHR · Reason for receipt of fees: The practice hosts NIHR approved commercial and non-commercial research and some of this may be funded by pharmaceutical companies · Total amount received: £1,000 to under £2,000

Other declarations

I am a partner at Whiteladies Medical Group. I work as a GP trainer. The practice owns the health centre and receives rental income from Lloyds Pharmacy.

The practice also has membership of the One care Consortium which received funding in 2014 and 2015 from the Prime Ministers Challenge Fund to increase access to primary care.